Cote d'Ivoire vs Sudan: The number of people with susceptibility test result for rifampicin
Cote d'Ivoire
8,494
in 2021
Sudan
6,193
in 2021
Cote d'Ivoire rank
25th
Sudan rank
27th
The number of people with susceptibility test result for rifampicin over time
- Cote d'Ivoire
- Sudan
How they compare
Cote d'Ivoire currently reports 8,494 against 6,193 in Sudan, a difference of 2,301.
That makes Cote d'Ivoire's figure about 1.4 times Sudan's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Cote d'Ivoire ahead.
Cote d'Ivoire ranks 25th and Sudan ranks 27th of 155 countries.
Across the 2 decades both report, Cote d'Ivoire averaged higher in 1 and Sudan in 1.
Head to head by decade
| Decade | Cote d'Ivoire | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3,175 | 1,894 | 1,281 | Cote d'Ivoire |
| 2020s | 4,890 | 5,498 | 609 | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cote d'Ivoire or Sudan?
- Cote d'Ivoire, at 8,494 against 6,193 in Sudan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cote d'Ivoire and Sudan?
- 2,301, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do Cote d'Ivoire and Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- Cote d'Ivoire ranks 25th and Sudan ranks 27th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.